68 related articles for article (PubMed ID: 32058312)
1. Racial disparities in colorectal cancer time-to-treatment and survival time in relation to diagnosing hospital cancer-related diagnostic and treatment capabilities.
Frankenfeld CL; Menon N; Leslie TF
Cancer Epidemiol; 2020 Apr; 65():101684. PubMed ID: 32058312
[TBL] [Abstract][Full Text] [Related]
2. Longer time-to-treatment but better survival for colorectal cancer patients presumptively not diagnosed in a hospital.
Frankenfeld CL; Leslie TF; Menon NM
Cancer Causes Control; 2021 Oct; 32(10):1185-1191. PubMed ID: 34160709
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in young-onset patients with colorectal, breast and testicular cancer.
Wu J; Ye J; Wu W; Fang D; Wang K; Yang L; Jiang X; Wang Q; Li L
J Cancer; 2019; 10(22):5388-5396. PubMed ID: 31632483
[No Abstract] [Full Text] [Related]
4. Effects of socioeconomic status and treatment disparities in colorectal cancer survival.
Le H; Ziogas A; Lipkin SM; Zell JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1950-62. PubMed ID: 18708384
[TBL] [Abstract][Full Text] [Related]
5. Neighborhood disadvantage and racial disparities in colorectal cancer incidence: a population-based study in Louisiana.
Danos DM; Ferguson TF; Simonsen NR; Leonardi C; Yu Q; Wu XC; Scribner RA
Ann Epidemiol; 2018 May; 28(5):316-321.e2. PubMed ID: 29678311
[TBL] [Abstract][Full Text] [Related]
6. Changes in Colorectal Cancer 5-Year Survival Disparities in California, 1997-2014.
Oh DL; Santiago-RodrÃguez EJ; Canchola AJ; Ellis L; Tao L; Gomez SL
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1154-1161. PubMed ID: 32371552
[TBL] [Abstract][Full Text] [Related]
7. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
[TBL] [Abstract][Full Text] [Related]
8. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
9. Racial-ethnic colorectal cancer survival disparities in the mountain west region: the case of Blacks compared to Whites.
Wassira LN; Pinheiro PS; Symanowski J; Hansen A
Ethn Dis; 2013; 23(1):103-9. PubMed ID: 23495630
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
11. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
12. Determinants of racial/ethnic colorectal cancer screening disparities.
Jerant AF; Fenton JJ; Franks P
Arch Intern Med; 2008 Jun; 168(12):1317-24. PubMed ID: 18574089
[TBL] [Abstract][Full Text] [Related]
13. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
14. Racial disparity in colorectal cancer: the role of ABO blood group.
Laryea JA; Siegel E; Burford JM; Klimberg SV
J Surg Res; 2013 Jul; 183(1):230-7. PubMed ID: 23290594
[TBL] [Abstract][Full Text] [Related]
15. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
Liss DT; Baker DW
Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
[TBL] [Abstract][Full Text] [Related]
16. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System.
Rabeneck L; Souchek J; El-Serag HB
Am J Gastroenterol; 2003 May; 98(5):1186-92. PubMed ID: 12809847
[TBL] [Abstract][Full Text] [Related]
17. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
Magaji BA; Moy FM; Roslani AC; Law CW
BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
[TBL] [Abstract][Full Text] [Related]
18. Use of Population-Based Cancer Registry Data to Determine the Effect of Timely Treatment on the Survival of Colorectal Cancer Patients.
Sandar M; Hsiang LG; Yew CK; Guat LB
J Registry Manag; 2015; 42(4):130-8. PubMed ID: 26938649
[TBL] [Abstract][Full Text] [Related]
19. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
Weiner AB; Keeter MK; Manjunath A; Meeks JJ
Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report.
Alkhouli M; Holmes DR; Carroll JD; Li Z; Inohara T; Kosinski AS; Szerlip M; Thourani VH; Mack MJ; Vemulapalli S
JACC Cardiovasc Interv; 2019 May; 12(10):936-948. PubMed ID: 31122351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
